Pharmaceutical Commerce: Top health industry issues for life sciences in 2014

March 2014
  • Print-friendly version

Michael Swanick, global leader of PwC's pharmaceutical and life sciences practice has shared findings based on our Health Research Institute's annual Top health industry issues report to address which issues we believe will directly impact the pharma, biotech and device manufacturers in 2014 (in no particular order are): Corporate venture capital, clinical research methods, counterfeit drugs and the new regulations intended to eliminate them as well as social, mobile, analytics and cloud technologies that are changing existing business models.